Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Medulloblastoma × Digoxin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Medulloblastoma 1 Leiomyosarcoma 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid Malignancies 1

Interventions

Cyclophosphamide 10 Magnetic Resonance Spectroscopy 7 Vincristine 6 Temozolomide 6 Specimen Handling 6 Etoposide 6 Cisplatin 6 X-Rays 4 Phantoms, Imaging 4 Carboplatin 4 etoposide phosphate 3 Thiotepa 3 Radiotherapy 3 Radiation 3 Platinum 3 Nuclear Medicine Department, Hospital 3 Methotrexate 3 Irinotecan 3 Filgrastim 3 Celecoxib 3 Biopsy 3 1,2-diaminocyclohexaneplatinum II citrate 3 ulixertinib 2 tazemetostat 2 pembrolizumab 2 palbociclib 2 olaparib 2 lutetium Lu 177 dotatate 2 ivosidenib 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06701812 2026-02-27

Digoxin Medulloblastoma Study

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡